We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Take a deep breath

2 Jul 2012 By Quentin Webb

The German company will pay $4.6 billion including debt for Lincare, a specialist in respiratory gases. That is a full-looking 9.3 times EBITDA and synergies will be limited. But Linde boosts its U.S. footprint – and secures a route to growth outside its consolidated core market.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)